Fig. 1 · Structure
Documents & Downloads
Carrageenan
Viral Inhibitor
Carrageenan is a potent viral inhibitor with applications in antiviral and anticancer research. It effectively inhibits the herpes simplex virus (HSV), HIV, and hepatitis A virus (HAV) by binding to the viral capsid, preventing viral attachment to heparan sulfate proteoglycans on the host cell surface. Carrageenan also exhibits cytotoxic effects on HeLa cancer cells and is relevant for studies on cervical cancer and genital warts. Furthermore, it induces acute non-immune inflammation and triggers a multifaceted inflammatory response characterized by proinflammatory mediator release, contributing to edema and neutrophil recruitment in experimental models.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 9000-07-1 |
| Applications | Viral Inhibitor |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.